Levothyroxine Sodium Tablet
Product Images NDC 31722-293

Product Visual Gallery

This gallery contains 32 technical images submitted to the FDA as part of the official labeling for Levothyroxine Sodium (NDC 31722-293). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Camber Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

100-mcg-1000s (100 Mcg 1000s)

This is a description of Levothyroxine Sodium Tablets, USP, a medication manufactured by Ascent Pharmaceuticals, Inc. and marketed by Camber Pharmaceuticals, Inc. The tablets come in a light-resistant container and should be stored at controlled room temperature. Each tablet contains 100 mcg (0.1 mg) of Levothyroxine sodium, and dosing information can be found in the prescribing information.*

FDA Label Image

100-mcg-90s (100 Mcg 90s)

This is a description of Levothyroxine medication in tablet form containing 100 micrograms of the active ingredient. The tablets come in a container with 90 tablets, and the medication is dispensed on prescription only. The manufacturing details are provided, including the manufacturer of the medication and the company for which it is manufactured. The recommended storage temperature is 20-25°C (68° - 77°F) with excursions allowed between 15 and 30°C (59°F and 86°F).*

FDA Label Image

112-mcg-1000s (112 Mcg 1000s)

Levothyroxine Sodium Tablets, USP by Revovz are a prescription medication available in a bottle containing 1000 tablets, with each tablet containing 112 mg of Levothyroxine Sodium, USP. The full prescribing information regarding dosage and administration should be consulted before use. The tablets should be dispensed in a light-resistant container and protected from light and moisture, and stored at controlled room temperature between 20°C and 25°C (68°F and 77°F). They are manufactured by Ascent Pharmaceuticals, Inc. for Camber Pharmaceuticals, Inc. in New Jersey.*

FDA Label Image

112-mcg-90s (112 Mcg 90s)

FDA Label Image

125-mcg-1000s (125 Mcg 1000s)

This is a product description for Levothyroxine Sodium Tablets, USP. Each tablet contains 125 mg of Levothyroxine sodium, used for a variety of thyroid conditions. The full prescribing information should be consulted for proper dosage and administration. The tablets should be stored in a light-resistant container, protected from moisture between 15 and 30°C. The manufacturer is Asoent Pharmaceuticals, located in Central Islip, NY, and the product is distributed by Camber Pharmaceuticals, Inc. in Piscataway, NJ.*

FDA Label Image

125-mcg-90s (125 Mcg 90s)

Levothyroxine Sodium Tablets, USP, is a prescription drug available in a pack of 90 tablets. The medicine is used for the administration of hypothyroidism. The recommended dosage may vary from case to case. It should be kept at room temperature ranging between 20°C - 25°C (68°F - 77°F); excursions to 15+ 200 30° (5nd) are allowed. The medicine is manufactured by Accent Pharmacecal, Central sip, N11722, and is distributed by Camber Framaceutcas, Focamay, WB854.*

FDA Label Image

137-mcg-1000s (137 Mcg 1000s)

This is a description of a medication called Levothyroxine Sodium Tablets, USP. The medication is sold in a bottle with 1000 tablets and each tablet contains 137 mg of Levothyroxine sodium. The direction for dosage and administration can be found in the full prescribing information. The tablets should be stored in a light-resistant container at a temperature range between 20° - 25°C (68° - 77°F) with excursions allowed between 15° and 30°C (59° and 86°F) and should be protected from moisture and light. The medication is manufactured by Ascent Pharmaceuticals, Inc. in Central Islip, NY, and distributed by Camber Pharmaceuticals, Inc. in Piscataway, NJ.*

FDA Label Image

137-mcg-90s (137 Mcg 90s)

This is a description of a medication called Levothyroxine Sodium Tablets, USP. The tablets contain 137 meg of the medication, also represented as 0.137 mg. The medication comes in a container, which should be stored at room temperature, between 20° and 25°C (68° - 77°F). The container should not be exposed to temperatures below 15°C or above 30°C. The tablets should be taken according to the dosage and administration guidelines provided. The medication is manufactured by Accent Pharmaceutical, located in Central sip, N 11722, and is distributed by Canber Framicoutcas in Focamay, W B854.*

FDA Label Image

150-mcg-1000s (150 Mcg 1000s)

Each tablet contains Levothyroxine sodium, USP 150 mg. It should be dispensed in a light-resistant container according to USP guidelines and stored at room temperature below 20°-25°C (68° - 77°F) with careful attention to displacement between 15° and 30°C (59° - 86°F). Manufactured by Rtan Pramacestas and sold in packs of 1000 tablets.*

FDA Label Image

150-mcg-90s (150 Mcg 90s)

This is a description for Levothyroxine Sodium Tablets, USP. The tablets have a strength of 150 mg (0.15 mg) and come in a bottle of 90 tablets, available only with a prescription. The dosage and administration information can be found on the packaging. The tablets should be stored at room temperature between 20°-25°C (68°-77°F) and should not be exposed to temperatures between 15-30°C (5°-86°F). The manufacturer is AooentPharmaceutical situated in Central Ship, N 11722 and the manufacturing has been done for Canber Framicoutcas in Focamay, W B854.*

FDA Label Image

175-mcg-1000s (175 Mcg 1000s)

Levothyroxine Sodium Tablets, USP are available in a container of 1000 tablets for prescription use only. Each tablet contains 175mg of Levothyroxine Sodium. Dosage and administration details are provided in the full prescribing information. The tablets should be stored in a tightly closed, light-resistant container at controlled room temperature. Ascent Pharmaceuticals, Inc., located in Central Islip, NY, manufactures the tablets, which are specifically for Camber Pharmaceuticals, Inc. of Piscataway, NJ.*

FDA Label Image

175-mcg-90s (175 Mcg 90s)

Levothyroxine Sodium Tablets, USP, is a prescription medication available in bottles containing 90 tablets. The dosage and administration information is missing, and it should be stored between 20°-25°C (68°-77°F). It is manufactured by AooantPasmaceucal and distributed by Canber ramacoutcas.*

FDA Label Image

200-mcg-1000s (200 Mcg 1000s)

Levothyroxine Sodium Tablets, USP with 200 mcg (0.2 mg) strength and 1000 tablets per container that should only be dispensed with a prescription. Each tablet consists of Levothyroxine sodium, USP 200 mg, and the prescribing information should be reviewed for dosage and administration instructions. The container should be a light-resistant one as per the USP requirements and stored within the temperature range of 20° - 25°C (68° - 77°F) with limited excursions allowed between 15° and 30°C (59° and 86°F) to protect the tablets from moisture and light. The manufacturer of the tablets is Ascent Pharmaceuticals, Inc. located in Central Slip, NY 11722 and the tablets are manufactured for Camber Pharmaceuticals, Inc. located at Piscataway, NJ 08854.*

FDA Label Image

200-mcg-90s (200 Mcg 90s)

This is a description of Levothyroxine Sodium Tablets, USP with a strength of 200 micrograms (0.2mg) and a quantity of 90 tablets. The medication should be stored in a temperature-controlled environment of 20-25 degrees Celsius. The manufacturer is Sandoz Pharmaceutical, and it is distributed by Cambrex Corporation. Dosage and administration information are not available.*

FDA Label Image

25-mcg-1000s (25 Mcg 1000s)

This is a prescription drug information for Revovz, a Levothyroxine Sodium Tablets, USP that comes in a bottle of 1000 tablets. Each tablet contains Levothyroxine sodium, USP 25 mg. The full prescribing information contains the dosage and administration instructions. It should be stored in a light-resistant container at controlled room temperature, between 20° - 25°C (68° - 77°F) and protected from moisture and light. The manufacturer is Ascent Pharmaceuticals, Inc., Central Islip, NY 11722, and it is manufactured for Camber Pharmaceuticals, Inc., Piscataway, NJ 08854.*

FDA Label Image

25-mcg-90s (25 Mcg 90s)

The text appears to be a mix of medical codes, drug names, and manufacturing information. It is not possible to generate a useful description without additional context.*

FDA Label Image

300-mcg-1000s (300 Mcg 1000s)

FDA Label Image

300-mcg-90s (300 Mcg 90s)

Levothyroxine Sodium Tablets, USP is a prescription medication dispensed in a 90 tablet container. Each tablet contains 100g of Levothyroxine Sodium in dosage form. It is dispensed in a child-resistant container. The medication should be stored at a controlled temperature between 20°C - 25°C (68°F - 77°F). The manufacturer is AooantPasmacescal, located in N 11722. Camber Pharmaceuticals, located in W 6854 is responsible for manufacturing the medication.*

FDA Label Image

50-mcg-1000s (50 Mcg 1000s)

Levothyroxine Sodium Tablets, USP is a prescription medication available in a bottle with 1000 tablets. Each tablet contains 50 mcg of Levathyroxine sodium, USP. Please refer to the full prescribing information for dosage and administration details. It should be dispensed in a light-resistant container as described in the USP and stored at a controlled room temperature of 20° - 25°C (66° - 77°F) with excursions allowed between 15° and 30°C (59° and 86°F). Protect it from moisture and light. The medicine is manufactured by Ascent Pharmaceuticas, Inc., Central Islip, NY 11722, and is marketed and distributed by Camber Pharmaceuticals, Inc., Piscataway, NJ 08854.*

FDA Label Image

50-mcg-90s (50 Mcg 90s)

Levothyroxine Sodium Tablets, USP is a medication that comes in a bottle containing 90 tablets, and is only available through a prescription. It contains 50mg of Loolyoane s, USP per pill and has specific instructions for dosage and storage. The recommended storage temperature is between 20-25°C (68°- 77°F) with excursions between 15+ 200 30° (50 nd 8- Pt to prevent degradation. The manufacturer is Aooant Parmacecal and it is manufactured for Canber Framacoutcas.*

FDA Label Image

75-mcg-1000s (75 Mcg 1000s)

This is a bottle of Levothyroxine Sodium Tablets, USP with 1000 tablets. Each tablet contains 75 meg of Levothyroxine sodium, USP. It is a prescription drug that requires proper dosage and administration. It should be stored in a light-resistant container at a controlled room temperature between 20° and 25°C (66° - 77°F). It should be protected from moisture and light. This product is manufactured by Ascent Pharmaceuticals Inc., located in Centalslp, NY and distributed by Camber Pharmaceuticals Inc., located in Picataway, NJ.*

FDA Label Image

75-mcg-90s (75 Mcg 90s)

FDA Label Image

88-mcg-1000s (88 Mcg 1000s)

This is a prescription-only medication for Levothyroxine Sodium tablets, USP containing 88 mcg per tablet. It is advised to refer to the full prescription information for proper dosage and administration. The medication must be stored in a controlled room temperature and dispensed in a light-resistant container. It should be protected from moisture and light. The medication is manufactured by Ascent Pharmaceuticals and distributed by Camber Pharmaceuticals.*

FDA Label Image

88-mcg-90s (88 Mcg 90s)

Levothyroxine Sodium Tablets, USP 88 088 mg, with a quantity of 90 tablets per bottle. It contains information on dosage with instructions on how to dispense and store between 20-25°C (68-77°F). The manufacturer is Account Pharmaceutical while the drug is sold by Camber Pharmaceuticals.*

FDA Label Image

Structure (Structure)

FDA Label Image

Table1 (Table1)

This text provides dosing guidelines for Levothyroxine Sodium Tablets for pediatric hypothyroidism based on the age and body weight of the patient. The daily dose per kg body weight varies for different age groups ranging from 10 meg/kg/day to 1.6 megkg/day. The dose should be adjusted according to clinical response and laboratory parameters.*

FDA Label Image

Table 2 (Table2)

This is a list of drugs that may decrease T4 absorption, potentially leading to hypothyroidism. Calcium carbonate and ferrous sulfate may bind to levothyroxine sodium tablets, whereas bile acid sequestrants and ion exchange resins are known to decrease its absorption. Other drugs like sucralfate, antacids and proton pump inhibitors may lead to hypochlorhydria, affect intragastric pH and reduce absorption, which is why patients should be monitored appropriately. Olistat should also be used with caution in conjunction with levothyroxine sodium tablets.*

FDA Label Image

Table3 (Table3)

This text provides a list of drugs and drug classes that may affect the transport of T4 and T3 in serum without affecting the concentration of FT4, ultimately resulting in changes in serum T4 and normal FT4 and TSH concentrations. The drugs are divided into two categories based on their effect on serum thyroxine-binding globulin (TBG) concentration. Salicylates inhibit the binding of T4 and T3 to TBG and transthyretin, causing an initial increase in serum FT4 followed by return to normal levels. Other drugs may cause protein-binding site displacement or inhibit the protein binding of T4 to TBG and albumin, resulting in an increase in the free T4 fraction in serum. Close monitoring of thyroid hormone parameters is recommended for patients taking these drugs.*

FDA Label Image

Table4 (Table4)

This text is a table providing information about drugs that may impact the hepatic metabolism of T4, which is used to treat hypothyroidism. The table includes information on the potential impact of drugs such as Phenobarbital and Rifampin on the metabolism of levothyroxine, which may result in changes in T4 serum levels. The text provides important information for healthcare professionals who prescribe T4, in order to avoid interactions that could change the efficacy of the medication.*

FDA Label Image

Table5 (Table5)

This is a description of drugs that may decrease conversion of T4 to T3. The administration of enzyme inhibitors reduces peripheral conversion of T4 to T3 which leads to reduced T3 levels. Serum T4 levels are typically normal but could potentially be slightly increased. Beta-adrenergic antagonists, short-term administration of large doses of glucocorticoids, and amiodarone are among the drugs that have these impacts. The article also explains the effects of other drugs in more detail.*

FDA Label Image

Table6 (Table6)

FDA Label Image

Table7 (Table7)

Table 7 shows the Pharmacokinetic Parameters of Thyroid Hormones in Euthyroid Patients. The table contains information about two hormones; Levothyroxine (T4) and Liothyronine (T3). The parameters include Thyroglobulin Ratio, Biological Potency, Half-life, and Protein binding percentage. The table also includes a note explaining that the estimated half-life of these hormones is 3 to 4 days in hyperthyroidism and 9 to 10 days in hypothyroidism.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.